🇺🇸 FDA
Patent

US 10034867

Quinuclidine derivatives and medicinal compositions containing the same

granted A61KA61K31/439A61K31/4745

Quick answer

US patent 10034867 (Quinuclidine derivatives and medicinal compositions containing the same) held by Almirall, S.A. expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall, S.A.
Grant date
Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/439, A61K31/4745, A61K31/56, A61K45/06